Transparent cosmetic product
Patent Information
- Application Number
- EP2023768184
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-10-17
- Filing Date
- 2023-09-04
- Publication Date
- 2025-08-27
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Conventional antiperspirant preparations using polyglyceryl esters with aluminum salts suffer from agglomeration and cloudiness under changing temperature conditions, leading to visible precipitates and reduced effectiveness when packaged in transparent containers, which consumers find undesirable.
A cosmetic product formulation containing at least one antiperspirant aluminum-containing active ingredient, polyglyceryl ester, and 1.4% or more by weight of alkyl glucoside, with the alkyl group having 6 to 14 carbon atoms, which maintains clarity and prevents agglomeration.
The formulation effectively prevents agglomeration and cloudiness, maintaining product clarity and antiperspirant performance even under changing temperature conditions, ensuring consumer acceptance and effectiveness.
Smart Images

Figure IMGF000013_0001
Abstract
Description
[0001] Transparent cosmetic product
[0002] The invention belongs to the cosmetic field and relates to a transparent cosmetic product.
[0003] Cosmetic products generally serve not only to make people look beautiful and attractive, but also contribute significantly to increased self-esteem and well-being. Accordingly, a wide variety of cosmetic products are used for daily skin cleansing and care.
[0004] One category of cosmetic products is deodorants and antiperspirants, which are applied under the armpits to prevent unpleasant odors. These unpleasant odors are caused by the decomposition of odorless sweat by bacteria. This decomposition produces fatty acid residues that characterize the typical sweat odor. Despite the fact that deodorants and antiperspirants are applied to the same area of skin and have the same objective, they differ in their technical effect.
[0005] Antiperspirants contain active ingredients that inhibit and reduce the flow of sweat. Antiperspirants containing aluminum can clog sweat glands.
[0006] Deodorants, on the other hand, are characterized by the fact that they do not inhibit the flow of sweat. Instead, deodorants are products that contain special antimicrobial agents that reduce the growth of bacteria such as Corynebacterium jeikeium or Staphylococcus epidermidis. Consequently, the decomposition of odorless sweat is reduced, resulting in fewer unpleasant odors.
[0007] Conventionally, antiperspirants and deodorants are applied to the skin either with a roller application device or as a spray. Both propellant-powered aerosol sprays and pump sprays operated by a hand pump are used. Depending on the application method, the cosmetic preparations vary significantly in their composition.
[0008] Antiperspirants that are applied to the skin using an application roller are described, among other things, in WO2010009880 A1. WO2010009880 A1 discloses, in Examples 1 to 4, antiperspirant-effective cosmetic preparations that contain a) aluminum chlorohydrate, b) butylene glycol and / or glycerin, and c) at least one emulsifier. Isocetheth-20, among others, is used as an emulsifier. The disclosed preparations containing butylene glycol are transparent.
[0009] A disadvantage, however, is that, in addition to the selection of polyols, the use of emulsifiers containing at least one polyethylene glycol subunit is crucial for the production of transparent perfume-containing preparations. Isocetheth-20, for example, contains 20 ethylene glycol units. However, there is a trend among consumers to avoid cosmetic products containing emulsifiers containing at least one polyethylene glycol subunit.
[0010] One alternative is to use polyglyceryl esters as a replacement for polyethylene glycol-containing emulsifiers. Polyglyceryl esters are esters formed from polyglycerol (e.g., polyglycerol-10) and at least one mono- or polybasic fatty acid.
[0011] However, the use of these emulsifiers has also proven problematic. For example, when polyglyceryl ester is used alone in combination with aluminum salts in antiperspirant preparations, agglomeration occurs after four months of storage at 40°C or after two weeks of storage in a temperature-change cabinet, which changes the temperature from -12°C to 60°C within one hour and vice versa. It is suspected that the agglomerated particles are salts of fatty acids from the polyglyceryl ester and aluminum. Furthermore, under the described temperature-change conditions, oil droplets containing oil-soluble perfume substances enlarge. This leads to clouding.
[0012] WO 2022 / 100992 A1 describes preparations containing polyglyceryl esters that, although they exhibit no phase separation 24 hours after preparation and are clear, exhibit the agglomerates described upon prolonged storage or the cloudiness described under alternating temperature conditions, as described above.
[0013] If such preparations are packaged in a transparent packaging, such as a glass roll-on applicator, the agglomerated particles become visible to the consumer. Such cosmetic products are not desired by consumers, especially since the antiperspirant effectiveness could be reduced by the formation of salts from polyglyceryl ester fatty acids and aluminum. Similar optical disadvantages arise from the enlargement of oil droplets, which leads to clouding (translucent formulation).
[0014] Accordingly, it was an object of the present invention to provide a cosmetic product which dispenses with the use of emulsifiers having at least one polyethylene glycol subunit and instead uses polyglyceryl esters, wherein these formulations should not have any precipitations or the described clouding, which could be displeasing to the consumer upon inspection or which would reduce the antiperspirant performance.
[0015] Surprisingly, the specific combination of the present invention was able to remedy this need.
[0016] The present invention relates to a cosmetic product comprising a) a container and b) a cosmetic preparation contained in the container comprising a. at least one antiperspirant, aluminum-containing active ingredient, b. at least one polyglyceryl ester, and c. at least 1.4% by weight of at least one alkyl glucoside, wherein the alkyl group has 6 to 14 carbon atoms.
[0017] Unless otherwise stated, all weight percentages (wt%) given below are based on the total weight of the preparation according to the invention. Where ratios of certain components are disclosed in the following description, these ratios refer to weight ratios of the components unless otherwise stated.
[0018] Unless otherwise stated, all tests and measurements were conducted under "normal conditions." The term "normal conditions" refers to 20°C, 1013 hPa, and a relative humidity of 50%.
[0019] The phrases “according to the invention”, “advantageous according to the invention”, “advantageous within the meaning of the present invention” etc. always refer in the context of the present disclosure to both the preparation according to the invention and the use according to the invention.
[0020] Unless otherwise stated, all weight percentages (wt%) given below are based on the total weight of the preparation according to the invention. Where ratios of certain components are disclosed in the following description, these ratios refer to weight ratios of the components unless otherwise stated.
[0021] If viscosity values are given in this disclosure, all values refer to a measurement at 25°C in a 150 ml wide-neck bottle (VWR No.: 807-001) using the Rheomat R 123 from proRheo. The Rheomat R 123 from proRheo GmbH is a rotational viscometer, i.e., a measuring body rotates in the substance to be measured. The force required to rotate the measuring body in the sample at a specified speed is measured. The viscosity is calculated from this torque, the speed of the measuring body, and the geometric dimensions of the measuring system used. The measuring body used is measuring body No. 1 (Article No. 200 0191), suitable for a viscosity range up to 10,000 [mPa s], speed range 62.5 mPa s. 1 , used.
[0022] The term “skin” refers exclusively to human skin.
[0023] The invention was able to surprisingly eliminate or reduce disadvantages of the prior art.
[0024] The container advantageously has a volume in the range of 10 to 300 ml, preferably in the range of 20 to 200 ml and particularly preferably in the range of 30 ml to 150 ml. The container advantageously has a bottom and a wall so that a liquid can be stored in the container. Furthermore, the container advantageously has an opening on its top which can be reversibly closed. Advantageously, the cosmetic product comprising the container and the preparation is provided with a closure cap over the opening. The closure cap can advantageously have a mechanism which enables the preparation to be dispensed from the container. Advantageously, this mechanism comprises a ball which is mounted in the closure cap in such a way that it transfers the preparation from the container to the outside when the ball is rotated, the transfer taking place by the preparation forming a film on the surface of the sphere.Accordingly, the preparation can be transferred to a surface outside the container by rolling the ball onto that surface.
[0025] Furthermore, it is advantageous if the container has at least one region that allows the preparation contained therein to be seen with the human eye. Advantageously, the container has at least one transparent region. In particular, the container has at least one transparent region in its wall structure.
[0026] In an advantageous embodiment, the container is characterized by being made of glass. This glass is advantageously transparent.
[0027] In a further advantageous embodiment, the container is characterized in that it is made of plastic, wherein the plastic is transparent.
[0028] The following descriptions apply to preparation.
[0029] According to the invention, the preparation contains at least one antiperspirant, aluminum-containing active ingredient.
[0030] It is also particularly advantageous if the antiperspirant, aluminum-containing active ingredient is selected from the group of aluminum salts with the formula [AI2(0H) m Cln], where m+n=6.
[0031] Examples of aluminum salts according to the invention are:
[0032] - Aluminum salts such as aluminum chloride AICI3, aluminum sulfate AI2(SO4)3
[0033] - Aluminium chlorides with the empirical formula [Al2(OH) m Cl n ], where m+n=6
[0034] - Aluminum chlorohydrate [Al2(OH)sCI] x H2O (ACH)
[0035] Standard Al complexes: Locron P (Clariant), Locron L (Clariant), Micro-Dry (Reheis), ACH-331 (Summit), Aloxicoll PF 40 (Giulini).
[0036] - Activated Al complexes: Reach 501 (Reheis), AACH-324 (Summit), AACH-7171 (Summit), Aloxicoll P (Giulini), Aloxicoll SD100
[0037] - Aluminum sesquichlorohydrate [AI2(OH)4.5Cli.5] x H2O Standard Al complexes: Aluminum sesquichlorohydrate (Reheis), AACH-308 (Summit)
[0038] - Activated Al complexes: Reach 301 (Reheis)
[0039] - Aluminum dichlorohydrate [Ah OH^Ch] x H2O
[0040] Furthermore, it is advantageous if at least one aluminum-zirconium salt is included as the antiperspirant, aluminum-containing active ingredient. These are advantageously selected from the group consisting of aluminum / zirconium trichlorohydrex glycine ([Al4Zr(OH)i3Cl3] x H2O x Gly), aluminum / zirconium tetrachlorohydrex glycine ([Al4Zr(OH)i2Cl4] x H2O x Gly), aluminum / zirconium pentachlorohydrex glycine ([Al8Zr(OH)23Cl5] x H2O x Gly), aluminum / zirconium octachlorohydrex glycine ([Al8Zr(OH)2oCl8] x H2O x Gly), and the glycine-free aluminum / zirconium salts. Aluminum / zirconium tetrachlorohydrex glycine is particularly preferred.
[0041] It is particularly advantageous if the antiperspirant, aluminum-containing active ingredient contained is aluminum chlorohydrate, aluminum sesquichlorohydrate and / or aluminum / zirconium tetrachlorohydrex glycine, with aluminum chlorohydrate being the most preferred.
[0042] Advantageously, the total proportion of the antiperspirant, aluminum-containing active ingredients is from 1 wt.% to 30 wt.%, preferably from 2 wt.% to 25 wt.% and particularly preferably from 5 wt.% to 22 wt.%, based on the total weight of the preparation.
[0043] It is particularly advantageous if the proportion of aluminum chlorohydrate is from 1 wt.% to 30 wt.%, preferably from 2 wt.% to 25 wt.% and particularly preferably from 5 wt.% to 22 wt.%, based on the total weight of the preparation.
[0044] The preparation further comprises at least one polyglyceryl ester. A polyglyceryl ester is an ester formed from polyglycerol (e.g., polyglycerol-10) and at least one mono- or polybasic fatty acid.
[0045] Erfindungsgemäß vorteilhafte Polyglycerylester sind Polyglyceryl-10 Caprate, Polyglyceryl-10 Laurate, Polyglyceryl-10 Trilaurate, Polyglyceryl-10 Myristate, Polyglyceryl-10 Dimyristate, Polyglyceryl-10 Oleate, Polyglyceryl-10 Dioleate, Polyglyceryl-10 Stearate, Polyglyceryl-10 Distearate, Polyglyceryl-10 Diisostearate, Polyglyceryl-6 Caprylate, Polyglyceryl-6 Dicaprylate, Polyglyceryl-6 Oleate, Polyglyceryl-6 Ricinoleate, Polyglyceryl-6 Stearate, Polyglyceryl-6 Behenate, Polyglyceryl-5 Laurate, Polyglyceryl-5 Myristate, Polyglyceryl-5 Oleat, Polyglyceryl-5 Dioleate, Polyglyceryl-5 Stearate, Polyglyceryl-4 Caprate, Polyglyceryl- 3 Caprate, Polyglyceryl-3 Cocoate, Polyglyceryl-3 Caprate / Caprylate / Succinate und / oder Polyglyceryl-3 Distearate.
[0046] It is further advantageous if the polyglyceryl ester(s) are formed from a polyglycerol having 3 to 10 glycerol subunits and at least one mono- or polybasic fatty acid having 4 to 22 carbon atoms. It is particularly advantageous if the polyglyceryl ester(s) are formed from a polyglycerol having 3 to 6 glycerol subunits and at least one fatty acid having 4 to 12 carbon atoms.
[0047] A particularly advantageous embodiment of the invention is characterized in that the preparation contains a polyglyceryl ester selected from the group polyglyceryl-4 caprate, polyglyceryl-6 caprylate and polyglyceryl-3 caprate / caprylate / succinate.
[0048] It is preferred if the proportion of polyglyceryl esters is from 0.5 to 8.0 wt.%, preferably from 1.0 to 6.0 wt.% and particularly preferably from 2.2 to 4.5 wt.%, based on the total weight of the preparation.
[0049] Es ist bevorzugt, wenn der Anteil von Polyglyceryl-10 Caprate, Polyglyceryl-10 Laurate, Polyglyceryl-10 Trilaurate, Polyglyceryl-10 Myristate, Polyglyceryl-10 Dimyristate, Polyglyceryl-10 Oleate, Polyglyceryl-10 Dioleate, Polyglyceryl-10 Stearate, Polyglyceryl-10 Distearate, Polyglyceryl-10 Diisostearate, Polyglyceryl-6 Caprylate, Polyglyceryl-6 Dicaprylate, Polyglyceryl-6 Oleate, Polyglyceryl-6 Ricinoleate, Polyglyceryl-6 Stearate, Polyglyceryl-6 Behenate, Polyglyceryl-5 Laurate, Polyglyceryl-5 Myristate, Polyglyceryl-5 Oleat, Polyglyceryl-5 Dioleate, Polyglyceryl-5 Stearate, Polyglyceryl-4 Caprate, Polyglyceryl- 3 Caprate, Polyglyceryl-3 Cocoate, Polyglyceryl-3 Caprate / Caprylate / Succinate und / oder Polyglyceryl-3 Distearate von 0,5 bis 8,0 Gew.-%, bevorzugt von 1 ,0 bis 6,0 Gew.-% und insbesondere bevorzugt von 2,2 bis 4,5 Gew.-% beträgt, bezogen auf das Gesamtgewicht der Zubereitung.
[0050] It is preferred if the proportion of the polyglyceryl esters of a polyglycerol having 3 to 10 glycerol subunits and at least one mono- or polybasic fatty acid having 4 to 22 carbon atoms is from 0.5 to 8.0% by weight, preferably from 1.0 to 6.0% by weight and particularly preferably from 2.2 to 4.5% by weight, based on the total weight of the preparation.
[0051] It is preferred if the proportion of the polyglyceryl esters of a polyglycerol with 3 to 6 glycerol subunits and at least one fatty acid having 4 to 12 carbon atoms is from 0.5 to 8.0 wt.%, preferably from 1.0 to 6.0 wt.% and particularly preferably from 2.2 to 4.5 wt.%, based on the total weight of the preparation.
[0052] It is preferred if the proportion of the polyglyceryl esters selected from the group polyglyceryl-4 caprate, polyglyceryl-6 caprylate and polyglyceryl-3 caprate / caprylate / succinate is from 0.5 to 8.0 wt.%, preferably from 1.0 to 6.0 wt.% and particularly preferably from 2.2 to 4.5 wt.%, based on the total weight of the preparation.
[0053] The preparation further comprises at least 1.4 wt.% of at least one alkyl glucoside, wherein the alkyl group has 6 to 14 carbon atoms. Advantageously, an alkyl glucoside is included which comprises an alkyl group with 8 to 10 carbon atoms.
[0054] It is particularly advantageous if caprylyl / capryl glucoside is included as an alkyl glucoside.
[0055] It is advantageous according to the invention if the proportion of alkyl glucosides having an alkyl group with 6 to 14 carbon atoms is from 1.4 to 6 wt.%, preferably 1.8 to 5.5 wt.% and particularly preferably from 2.0 to 5.0 wt.%, based on the total weight of the preparation.
[0056] It is advantageous according to the invention if the proportion of alkyl glucosides having an alkyl group with 8 to 10 carbon atoms is from 1.4 to 6 wt.%, preferably 1.8 to 5.5 wt.% and particularly preferably from 2.0 to 5.0 wt.%, based on the total weight of the preparation.
[0057] It is particularly preferred if caprylyl / capryl glucoside is contained in a proportion of 1.4 to 6 wt.%, preferably 1.8 to 5.5 wt.% and particularly preferably 2.0 to 5.0 wt.% based on the total weight of the preparation.
[0058] It is advantageous if the preparation contains substances comprising at least one polyethylene glycol subunit in proportions of less than 0.5 wt.%, preferably less than 0.3 wt.%, preferably less than 0.1 wt.%, and particularly preferably 0 wt.%. A polyethylene glycol subunit consists of at least two consecutive ethylene glycol units.
[0059] Advantageous preparations of the present invention advantageously contain further emulsifiers in proportions of less than 0.5% by weight, preferably less than 0.4% by weight, preferably less than 0.3% by weight, preferably less than 0.2% by weight, preferably less than 0.1% by weight and particularly preferably 0% by weight, in each case based on the total weight of the preparation.
[0060] Furthermore, it is advantageous according to the invention for the preparation to contain butylene glycol and / or 1,3-propanediol. The proportion of butylene glycol and / or 1,3-propanediol is advantageously from 1 to 40 wt.%, preferably from 2 to 30 wt.%, and particularly preferably from 4 to 25 wt.%, based on the total weight of the preparation. It is particularly advantageous if 1,3-propanediol is present.
[0061] Furthermore, it is advantageous if the preparation additionally contains at least one or more perfume substances which are liquid under normal conditions. Advantageously chosen perfume substances are selected from essential oils, geraniol, geranyl acetate, linalool, linalyl acetate, tetrahydrolinalool, citronellol, citronellyl acetate, dihydromyrcenol, dihydromyrcenyl acetate, tetrahydromyrcenol, terpineol, terpinyl acetate, nopol, nopyl acetate, 2-phenyl benzyl alcohol, benzyl acetate, benzyl salicylate, benzyl benzoate, styrallyl acetate, amyl salicylate, dimethyl benzyl carbinol, trichloromethylphenyl carbinyl acetate, p-tert-butylcyclohexyl acetate, isononyl acetate, vetiveryl acetate alpha-hexylcinamaldehyde, 2-methyl-3-(p-tert-butylphenyl)propanol, 2-methyl-3-(p-isopropylphenyl)propanal, 3-(p-tert.-Butylphenyl) propanal, tricyclodecenyl acetate, tricyclodecenyl propionate, 4-(4-hydroxy-4-methylpentyl)-3-cyclohexenecarbaldehyde, 4-(4-methyl-3-pentenyl)-3-cyclohexenecarbaldehyde, 4-acetoxy-3-pentyltetrahydropyran, methyldihydrojasmonate, 2 -heptylcyclopentanone, 3-methyl-2-pentylcyclopentanone, n-decanal, 9-decenol-1, phenoxyethyl isobutyrate, phenylacetaldehyde dimethyl acetal, phenylacetaldehyde diethyl acetal, geranonitrile, citronellonitrile, cedryl acetate, 3-isocamphylcyclohephane, ethine, heliotropine, coumarin, eugenol, Vanillin, Diphenyloxide, Hydroxycitronellal, Ionone, Methylionone, Isomethyl ionone, iron, cis-3-hexenol and esters thereof, indan musk fragrances, tetralin musk fragrances, isochroman musk fragrances, macrocyclic ketones, macrolactone muskrone, macrolactone muskrone brassylate, and aromatic nitro musk fragrances. Other perfume components that may be included but are not specifically preferred are listed in Arctander, Perfume and Flavor Chemicals (Chemicals), Vol.I and II (1969) and Arctander, Perfume and Flavour Materials of Natural Origin (1960). The proportion of perfume substances liquid under normal conditions is advantageously from 0.001 to 2 wt.%, preferably from 0.005 to 1.5 wt.%, and particularly preferably from 0.01 to 1.4 wt.%, based on the total weight of the preparation.
[0062] In one embodiment of the invention, it is advantageous if propylene glycol is included, wherein the proportion of propylene glycol is advantageously from 0.5 to 2.5 wt.%, based on the total weight of the preparation.
[0063] It is further advantageous according to the invention if the preparation contains further polyols in proportions of less than 0.5% by weight, preferably less than 0.4% by weight, preferably less than 0.3% by weight, preferably less than 0.2% by weight, preferably less than 0.1% by weight and particularly preferably 0% by weight, in each case based on the total weight of the preparation.
[0064] It is further advantageous according to the invention if the preparation contains glycerol and / or pentylene glycol in total proportions of less than 0.5% by weight, preferably less than 0.4% by weight, preferably less than 0.3% by weight, preferably less than 0.2% by weight, preferably less than 0.1% by weight and particularly preferably 0% by weight, in each case based on the total weight of the preparation.
[0065] Furthermore, it is advantageous if the preparation contains water, wherein it is preferred if the proportion of water is from 40 to 90% by weight, particularly preferably 45 to 85% by weight, wherein the information relates to the total weight of the preparation.
[0066] Furthermore, according to the invention, the preparations may contain additional excipients. These may include dyes, thickeners, deodorants, or other ingredients.
[0067] Examples:
[0068] The following examples are intended to illustrate the preparations and products of this invention, without intending to limit the invention to these examples. The numerical values in the examples are percentages by weight based on the total weight of the preparations.
[0069] The formulations marked below with the abbreviation Comp.X, where X is a consecutive number, are comparative examples not according to the invention. Examples according to the invention are abbreviated to Ex.X, where X also stands for a consecutive number.
[0070] The sample formulations were stored in a glass container with a cap or a screw cap containing a ball suitable for typical roll-on application. The roll-on attachment was designed so that the ball inside could be rotated on its surface to transfer the preparation from inside to outside the container. The containers had a volume of 50 ml. The glass was transparent to the human eye.
[0071] If an example is described below as transparent, it has a transmission of at least 80% at 880 nm. The measurement is carried out using a Turbiscan Lab Expert Analyzer using the principle of multiple light scattering at 30.5°C. Backscattering is detected at a scattering angle of 45° relative to the incoming light beam at 0°, and transmission is detected at a scattering angle of 180° relative to the incoming light beam at 0°. The measurement of backscattering and transmission is height-resolved; the resolution in the Turbiscan lab is 40 pm. The device was calibrated using standard cells filled with silicone oil and made of Teflon. Preparations with less than 80% transmission are described as translucent or cloudy.
[0072] Particulate agglomerates were evaluated by visual inspection using the human eye. Where agglomerates were detected, this is indicated in the table below.
[0073] All samples were stored for 14 days in a temperature-variable chamber. The chamber continuously varied the temperature between -12°C and 60°C, with a temperature change from -12°C to 60°C and vice versa within 24 hours, and from -12°C to +60°C and vice versa within 24 hours each taking 1 hour.
[0074]
Claims
Patent claims 1 . A cosmetic product comprising a) a container and b) a cosmetic preparation contained in the container comprising a. at least one antiperspirant, aluminum-containing active ingredient, b. at least one polyglyceryl ester, and c. at least 1.4 wt. % of at least one alkyl glucoside, wherein the alkyl group has 6 to 14 carbon atoms.
2. Product according to claim 1, characterized in that the container has a volume in the range of 10 to 300 ml, preferably in the range of 20 to 200 ml and particularly preferably in the range of 30 ml to 150 ml.
3. Product according to one of the preceding claims, characterized in that the container has an opening on its top which can be closed reversibly, the cosmetic product comprising the container and the preparation being provided with a closure cap over the opening and the closure cap having a mechanism which enables the preparation to be dispensed from the container, this mechanism comprising a ball which is mounted in the closure cap in such a way that it transfers the preparation from the container to the outside by rotating the ball, the transfer taking place by the formation of a film of the preparation on the surface of the ball.
4. Product according to one of the preceding claims, characterized in that the container has at least one area that allows the preparation contained therein to be seen with the human eye.
5. Product according to one of the preceding claims, characterized in that the antiperspirant, aluminum-containing active ingredient is selected from the group of aluminum salts with the formula [AI2(OH) m Cl n ], where m+n=6.
6. Product according to one of the preceding claims, characterized in that the antiperspirant, aluminum-containing active ingredient contained is aluminum chlorohydrate, aluminum sesquichlorohydrate and / or aluminum / zirconium tetrachlorohydrex glycine, with aluminum chlorohydrate being the most preferred.
7. Product according to one of the preceding claims, characterized in that the total proportion of the antiperspirant, aluminum-containing active ingredients is from 1 wt.% to 30 wt.%, preferably from 2 wt.% to 25 wt.% and particularly preferably from 5 wt.% to 22 wt.%, based on the total weight of the preparation. Produkt nach einem der vorhergehenden Ansprüche dadurch gekennzeichnet, dass der Polglycerylester gewählt ist aus der Gruppe Polyglyceryl-10 Caprate, Polyglyceryl-10 Laurate, Polyglyceryl-10 Trilaurate, Polyglyceryl-10 Myristate, Polyglyceryl-10 Dimyristate, Polyglyceryl-10 Oleate, Polyglyceryl-10 Dioleate, Polyglyceryl-10 Stearate, Polyglyceryl-10 Distearate, Polyglyceryl-10 Diisostearate, Polyglyceryl-6 Caprylate, Polyglyceryl-6 Dicaprylate, Polyglyceryl-6 Oleate, Polyglyceryl-6 Ricinoleate, Polyglyceryl-6 Stearate, Polyglyceryl-6 Behenate, Polyglyceryl-5 Laurate, Polyglyceryl-5 Myristate, Polyglyceryl-5 Oleat, Polyglyceryl-5 Dioleate, Polyglyceryl-5 Stearate, Polyglyceryl-4 Caprate, Polyglyceryl-3 Caprate, Polyglyceryl-3 Cocoate, Polyglyceryl-3 Caprate / Caprylate / Succinate und Polyglyceryl- 3 Distearate.Product according to one of the preceding claims, characterized in that the polyglyceryl ester(s) are formed from a polyglycerol having 3 to 10 glycerol subunits and at least one mono- or polybasic fatty acid having 4 to 22 carbon atoms. Product according to one of the preceding claims, characterized in that the polyglyceryl ester(s) are formed from a polyglycerol having 3 to 6 glycerol subunits and at least one fatty acid having 4 to 12 carbon atoms. Product according to one of the preceding claims, characterized in that the proportion of polyglyceryl esters is from 0.5 to 8.0 wt.%, preferably from 1.0 to 6.0 wt.%, and particularly preferably from 2.2 to 4.5 wt.%, based on the total weight of the preparation.Product according to one of the preceding claims, characterized in that the proportion of the polyglyceryl esters selected from the group polyglyceryl-4 caprate, polyglyceryl-6 caprylate and polyglyceryl-3 caprate / caprylate / succinate is from 0.5 to 8.0 wt.%, preferably from 1.0 to 6.0 wt.% and particularly preferably from 2.2 to 4.5 wt.%, based on the total weight of the preparation. Product according to one of the preceding claims, characterized in that an alkyl glucoside is contained which comprises an alkyl group having 8 to 10 carbon atoms. Product according to one of the preceding claims, characterized in that the proportion of the alkyl glucosides comprising an alkyl group having 6 to 14 carbon atoms is from 1.4 to 6 wt.%, preferably 1.8 to 5.5 wt.% and particularly preferably from 2.0 to 5.0 wt.%, based on the total weight of the preparation. Product according to one of the preceding claims, characterized in that caprylyl / capryl glucoside is present and the proportion of caprylyl / capryl glucoside is from 1.4 to 6 wt.%, preferably from 1.8 to 5.5 wt.%, and particularly preferably from 2.0 to 5.0 wt.%, based on the total weight of the preparation. Product according to one of the preceding claims, characterized in that 1,3-propanediol is present in a proportion of from 1 to 40 wt.%, preferably from 2 to 30 wt.%, and particularly preferably from 4 to 25 wt.%, based on the total weight of the preparation.